TY - JOUR
T1 - SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs
T2 - insight from a national study cohort at the Faroe Islands
AU - Jarlhelt, Ida
AU - Hansen, Cecilie Bo
AU - Pérez-Alós, Laura
AU - Weihe, Pál
AU - Petersen, Maria Skaalum
AU - Garred, Peter
N1 - Copyright © 2024 Jarlhelt, Hansen, Pérez-Alós, Weihe, Petersen and Garred.
PY - 2024
Y1 - 2024
N2 - BACKGROUND: Knowledge about SARS-CoV-2 antibody dynamics in neonates and direct comparisons with maternal antibody responses are not well established. This study aimed to characterize and directly compare the maternal and infant antibody response in a national birth cohort from the Faroe Islands.METHODS: The levels of immunoglobulins (Ig) targeting the receptor binding domain (RBD) of the spike protein and the nucleocapsid protein (N protein) of SARS-CoV-2 were investigated in maternal blood and umbilical cord blood from neonates. The study included 537 neonates and 565 mothers from the Faroe Islands, and follow-up samples were collected 12 months after birth. Multiple linear regression models were used to assess associations of maternal parameters with maternal and neonatal Ig levels and pregnancy outcomes.RESULTS: The finding showed that neonates acquired varying levels of SARS-CoV-2 antibodies through transplacental transfer, and the levels were significantly influenced by the mother's vaccination and infection status. The study also found that maternal vaccination and the presence of SARS-CoV-2 antibodies targeting spike RBD were associated with gestational age and APGAR scores. Furthermore, the anti-RBD and -N protein-specific antibody response dynamics during 12 months after birth exhibited differences between mothers and children. RBD and N protein responses were maintained at follow-up in the mother's cohort, while only the N protein response was maintained at follow-up in the children's cohort.CONCLUSION: In conclusion, SARS-CoV-2-specific immune responses in newborns rely on maternal immunity, while the persistence of SARS-CoV-2-specific Igs appears to be differently regulated between mothers and children. The study provides new insights into the dynamics of SARS-CoV-2-specific immune responses in newborns and underscores the nuanced relationship between maternal factors and neonatal humoral responses.
AB - BACKGROUND: Knowledge about SARS-CoV-2 antibody dynamics in neonates and direct comparisons with maternal antibody responses are not well established. This study aimed to characterize and directly compare the maternal and infant antibody response in a national birth cohort from the Faroe Islands.METHODS: The levels of immunoglobulins (Ig) targeting the receptor binding domain (RBD) of the spike protein and the nucleocapsid protein (N protein) of SARS-CoV-2 were investigated in maternal blood and umbilical cord blood from neonates. The study included 537 neonates and 565 mothers from the Faroe Islands, and follow-up samples were collected 12 months after birth. Multiple linear regression models were used to assess associations of maternal parameters with maternal and neonatal Ig levels and pregnancy outcomes.RESULTS: The finding showed that neonates acquired varying levels of SARS-CoV-2 antibodies through transplacental transfer, and the levels were significantly influenced by the mother's vaccination and infection status. The study also found that maternal vaccination and the presence of SARS-CoV-2 antibodies targeting spike RBD were associated with gestational age and APGAR scores. Furthermore, the anti-RBD and -N protein-specific antibody response dynamics during 12 months after birth exhibited differences between mothers and children. RBD and N protein responses were maintained at follow-up in the mother's cohort, while only the N protein response was maintained at follow-up in the children's cohort.CONCLUSION: In conclusion, SARS-CoV-2-specific immune responses in newborns rely on maternal immunity, while the persistence of SARS-CoV-2-specific Igs appears to be differently regulated between mothers and children. The study provides new insights into the dynamics of SARS-CoV-2-specific immune responses in newborns and underscores the nuanced relationship between maternal factors and neonatal humoral responses.
KW - Humans
KW - Female
KW - SARS-CoV-2/immunology
KW - COVID-19/immunology
KW - Pregnancy
KW - Antibodies, Viral/blood
KW - Spike Glycoprotein, Coronavirus/immunology
KW - Infant, Newborn
KW - Coronavirus Nucleocapsid Proteins/immunology
KW - Adult
KW - Immunity, Maternally-Acquired
KW - Infant
KW - Male
KW - Cohort Studies
KW - Phosphoproteins/immunology
KW - Pregnancy Complications, Infectious/immunology
KW - Fetal Blood/immunology
UR - http://www.scopus.com/inward/record.url?scp=85198655233&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2024.1418678
DO - 10.3389/fimmu.2024.1418678
M3 - Journal article
C2 - 39021574
SN - 1664-3224
VL - 15
SP - 1418678
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1418678
ER -